Agenda

While market research has been the primary means of gathering information of business insights teams, the fact remains that it is squarely focused on the “customers” piece of the equation, giving rise to some blind spots. Where competitive intelligence (CI) teams and vendors exist, they tend to operate in relative isolation from those handling market research for the same product or space. Through this talk, we attempt to explain when and how CI can be interwoven into market research to unlock a unique perspective of the market that is not only more comprehensive but also more forward-looking and actionable.

At the same time, research has shown that the industry has been seeing HCP push-back due to over-communication
and in some cases, “spamming.” Based upon recent voice of customer research funded and conducted by ThinkGen
researchers, Audrey Wu (VP) and Muhammad Asim (SVP) will provide some insights into the drive towards more personalized, individualized and customized modes of HCP communication, with a focus on messaging. This talk is aimed at helping marketing researchers understand today’s current HCP engagement landscape, and to leverage Dynamic Messaging to tailor the message to HCP’s unique habits and communication profile preferences to help drive the success of the brand.

It’s no wonder why there’s so little trust in demand study outcomes among biopharma executives and brand leads. But what is driving the need to apply such large discounts? Is there a better way to design demand studies to control for sources of error that contribute to the need to discount? In this presentation, we will compare two common approaches to demand studies – global allocations and patient scenarios – and the potential sources of error that methodology selection can introduce. We will also discuss the benefits (and relatively limited drawbacks) of patient scenarios over global allocations.